RecruitingPhase 3NCT04702581
A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery
Studying Oligodendroglioma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Hospices Civils de Lyon
- Intervention
- PCV chemotherapy(drug)
- Enrollment
- 280 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2030
Study locations (26)
- CHU d'Amiens-Picardie Site Sud, Amiens, France
- Institut de Cancerologie de l'Ouest, Angers, France
- CHU de Bordeaux Hôpital Saint André, Bordeaux, France
- Institut de Cancérologie et Hematologie (ICH) - CHRU Brest, Hopital Morvan, Brest, France
- Hospices Civils de Lyon, Bron, France
- CHU de Caen, Caen, France
- Hôpital d'Instruction des Armées PERCY, Clamart, France
- Hôpital Pasteur - Hôpitaux civils de Colmar, Colmar, France
- Centre Georges Francois Leclerc, Dijon, France
- Hôpital Roger Salengro CHU de Lille, Lille, France
- CHU de Limoges, Limoges, France
- Centre Léon Bérard, Lyon, France
- Hôpital Timone, Marseille, France
- CHU de Nice Hôpital Pasteur, Nice, France
- Hôpital Saint-Louis, AP-HP, Paris, France
- +11 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04702581 on ClinicalTrials.govOther trials for Oligodendroglioma
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06989086FearLess in NeuroOncologyVirginia Commonwealth University
- ACTIVE NOT RECRUITINGPHASE1NCT06254326ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult PatientsUniversity of Florida
- RECRUITINGPHASE2NCT05512351Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse OligodendrogliomaHenan Provincial People's Hospital
- RECRUITINGNANCT05190172PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmasOslo University Hospital
- RECRUITINGPHASE3NCT05331521A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).University Hospital Heidelberg
- ACTIVE NOT RECRUITINGPHASE2NCT03969706Abemaciclib in Patients with OligodendrogliomaStephen Bagley, MD, MSCE